| Autor: |
Bultema JB; Microbial Physiology, Groningen Biomolecular Sciences and Biotechnology Institute (GBB), University of Groningen, Nijenborgh 7, 9747 AG Groningen, The Netherlands., Kuipers BJ; FrieslandCampina Research, Stationsplein 4, 3818 LE Amersfoort, The Netherlands., Dijkhuizen L; Microbial Physiology, Groningen Biomolecular Sciences and Biotechnology Institute (GBB), University of Groningen, Nijenborgh 7, 9747 AG Groningen, The Netherlands. |
| Jazyk: |
angličtina |
| Zdroj: |
FEBS open bio [FEBS Open Bio] 2014 Nov 12; Vol. 4, pp. 1015-20. Date of Electronic Publication: 2014 Nov 12 (Print Publication: 2014). |
| DOI: |
10.1016/j.fob.2014.11.002 |
| Abstrakt: |
The Bacillus circulans ATCC 31382 β-galactosidase (BgaD) is a retaining-type glycosidase of glycoside hydrolase family 2 (GH2). Its commercial enzyme preparation, Biolacta N5, is used for commercial-scale production of galacto-oligosaccharides (GOS). The BgaD active site and catalytic amino acid residues have not been studied. Using bioinformatic routines we identified two putative catalytic glutamates and two highly conserved active site histidines. The site-directed mutants E447N, E532Q, and H345F, H379F had lost (almost) all catalytic activity. This confirmed their essential role in catalysis, as general acid/base catalyst (E447) and nucleophile (E532), and as transition state stabilizers (H345, H379), respectively. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Plný text